EUVIMEDEUVIMED entdecken
Open Access

Amyloid-beta and tau protein beyond Alzheimer’s disease

Morteza Abyadeh, Vivek Gupta, Joao A Paulo, Arezoo Gohari Mahmoudabad, Sina Shadfar, Shahab Mirshahvaladi, Veer Gupta, Christine T O Nguyen, David I Finkelstein, Yuyi You, Paul A Haynes, Ghasem H Salekdeh und 2 weitere

Neural Regeneration Research · 2024-06 · 19 (6) · 1262-1276

DOI: 10.4103/1673-5374.386406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neural Regeneration Research, online erschienen am 02.10.2023. Verfasst von Morteza Abyadeh und 13 weiteren Autor:innen. Beteiligte Einrichtung: ProGene Technologies Pty Ltd., Sydney, NSW, Australia. Die Arbeit wurde bisher 118-mal zitiert (Crossref) und nennt 383 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to play key roles in Alzheimer’s disease pathogenesis and are considered the main pathological hallmarks of this devastating disease. Physiologically, these two proteins are produced and expressed within the normal human body. However, under pathological conditions, abnormal expression, post-translational modifications, conformational changes, and truncation can make these proteins prone to aggregation, triggering specific disease-related cascades. Recent studies have indicated associations between aberrant behavior of amyloid-beta and tau proteins and various neurological diseases, such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, as well as retinal neurodegenerative diseases like Glaucoma and age-related macular degeneration. Additionally, these proteins have been linked to cardiovascular disease, cancer, traumatic brain injury, and diabetes, which are all leading causes of morbidity and mortality. In this comprehensive review, we provide an overview of the connections between amyloid-beta and tau proteins and a spectrum of disorders.

Autor:innen und Institutionen

  • ProGene Technologies Pty Ltd., Sydney, NSW, Australia.
  • Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie Medical School, Macquarie University, Macquarie Park, North Ryde, Sydney, NSW, Australia.
  • Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
  • School of Medicine, Deakin University, Geelong, VIC, Australia.
  • Department of Optometry and Vision Sciences, School of Health Sciences, Faculty of Medicine Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
  • The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.

ORCID-Profile: Mehdi Mirzaei

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Abyadeh, M., Gupta, V., Paulo, J. A., Mahmoudabad, A. G., Shadfar, S., Mirshahvaladi, S., Gupta, V., Nguyen, C. T. O., Finkelstein, D. I., You, Y., Haynes, P. A., Salekdeh, G. H., Graham, S. L., & Mirzaei, M. (2024). Amyloid-beta and tau protein beyond Alzheimer’s disease. Neural Regeneration Research, 19(6), 1262-1276. https://doi.org/10.4103/1673-5374.386406

Vancouver

Abyadeh M, Gupta V, Paulo JA, Mahmoudabad AG, Shadfar S, Mirshahvaladi S, et al. Amyloid-beta and tau protein beyond Alzheimer’s disease. Neural Regeneration Research. 2024;19(6):1262-1276. doi:10.4103/1673-5374.386406

BibTeX
@article{Abyadeh2024,
  author = {Abyadeh, Morteza and Gupta, Vivek and Paulo, Joao A and Mahmoudabad, Arezoo Gohari and Shadfar, Sina and Mirshahvaladi, Shahab and Gupta, Veer and Nguyen, Christine T O and Finkelstein, David I and You, Yuyi and Haynes, Paul A and Salekdeh, Ghasem H and Graham, Stuart L and Mirzaei, Mehdi},
  title = {Amyloid-beta and tau protein beyond Alzheimer’s disease},
  journal = {Neural Regeneration Research},
  year = {2024},
  volume = {19},
  number = {6},
  pages = {1262--1276},
  doi = {10.4103/1673-5374.386406}
}
Kostenlos starten →